CONMED Adjusts Guidance Due to Hurricane Aftermath
The company's orthopedic sales grew nearly 5% in the third quarter of 2024 but hurricane impacts will impact fourth quarter results. Nov 04, 2024
Stryker Flourishes in Market’s New Normal
The company's orthopedic sales grew in the double digits during the third quarter of 2024 amid robust volume and demand. Nov 01, 2024
Investors and Startups Chart Future Course of Orthopedics
Emptying out our notebook from MNVC 2024 with investor advice to start-ups, new technology themes, and exciting developments from VISIE. Nov 01, 2024
BONESUPPORT Drives Record Sales For CERAMENT G in U.S.
The company grew over 50% in the third quarter of 2024, driven by continued U.S. market penetration and hospital approvals. Oct 25, 2024
Speed and Discipline: Enovis’ Roadmap to Growth
We spoke to Enovis CEO Matt Trerotola about M&A integration, enabling technologies and the company's strategy in the foot and ankle market. Oct 24, 2024
The State of the Sports Medicine Market
This video delves into the state of the sports medicine market, exploring the trends shaping its trajectory to over $8.5 billion by 2027. Oct 21, 2024
Johnson & Johnson MedTech Slowed by Orthopedic Headwinds in 3Q24
The company's orthopedic sales grew in the low single digits in the third quarter of 2024 on restructuring and APAC headwinds. Oct 16, 2024
Trauma Sales Remain Resilient Despite Choppy Market
The top players in the trauma space are growing in line with historical averages despite a choppy operating environment in recent years. Oct 10, 2024
Stryker Expands Reach Throughout Trauma Segment
We spoke to Tim Lanier, Stryker’s President, Trauma and Extremities, about innovation and expansion in both core trauma and foot and ankle. Sep 26, 2024
3 Trends We’re Watching in a Changing Spine Market
Consolidation, enabling technology and implant breakthroughs are creating long term change in the spine market. Sep 19, 2024
